Cargando…
Cornel Iridoid Glycoside Ameliorated Alzheimer's Disease-Like Pathologies and Necroptosis through RIPK1/MLKL Pathway in Young and Aged SAMP8 Mice
BACKGROUND: Aging is an important risk factor for sporadic Alzheimer's disease (AD) and other neurodegenerative diseases. Senescence-accelerated mouse-prone 8 (SAMP8) is used as an animal model for brain aging and sporadic AD research studies. The aim of the current study was to investigate the...
Autores principales: | Ma, Denglei, Li, Yanzheng, Zhu, Yanqiu, Wei, Weipeng, Zhang, Li, Li, Yali, Li, Lin, Zhang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407981/ https://www.ncbi.nlm.nih.gov/pubmed/34475966 http://dx.doi.org/10.1155/2021/9920962 |
Ejemplares similares
-
Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice
por: Ma, Denglei, et al.
Publicado: (2021) -
Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation
por: Yang, Cui-cui, et al.
Publicado: (2013) -
Cornel Iridoid Glycoside Improves Locomotor Impairment and Decreases Spinal Cord Damage in Rats
por: Tang, Wen-jing, et al.
Publicado: (2016) -
Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction
por: Yang, Cuicui, et al.
Publicado: (2020) -
The Reduction of Tau Hyperphosphorylation by Cornel Iridoid Glycosides Is Mediated by Their Influence on Calpain Activity
por: Guo, Kaiwen, et al.
Publicado: (2022)